Home
Venmax Drugs & Pharmaceuticals Ltd Share Price Today
Venmax Drugs & Pharmaceuticals Ltd
BSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹14.57Cr
Venmax Drugs & Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Venmax Drugs & Pharmaceuticals Ltd Fundamentals
Venmax Drugs & Pharmaceuticals Ltd Delivery and Volume
About Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It
| Name | Designation |
|---|---|
| N Krishnaniah | Managing Director |
| Meena Kumari Pilli | Independent Director |
| Swapneswar Mishra | Non Executive Director |
| Sandan Grover | Company Sec. & Compli. Officer |
| Mr Reddeppa Gundluru | Independent Director |
| D. Rakesh Reddy | Independent Director |
| Sadhanala Venkata Rao | WTD & Additional Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Venmax Drugs & Pharmaceuticals Ltd FAQs
How do I Buy Venmax Drugs & Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Venmax Drugs & Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Venmax Drugs & Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Venmax Drugs & Pharmaceuticals Ltd's share price is ₹27.22 as of 2025-05-07.
What is the PE ratio of Venmax Drugs & Pharmaceuticals Ltd?
Venmax Drugs & Pharmaceuticals Ltd's P/E ratio is - times as of 2025-05-07.
What is the PB ratio of Venmax Drugs & Pharmaceuticals Ltd?
Venmax Drugs & Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Venmax Drugs & Pharmaceuticals Ltd's market capitalization is ₹14.57 Cr as on 2025-05-07.
What is the ROE of Venmax Drugs & Pharmaceuticals Ltd?
The current financial records of Venmax Drugs & Pharmaceuticals Ltd show a 1.15% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Venmax Drugs & Pharmaceuticals Ltd?
According to Venmax Drugs & Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹0.02, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Venmax Drugs & Pharmaceuticals Ltd?
The 52-week high/low price of a Venmax Drugs & Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Venmax Drugs & Pharmaceuticals Ltd's 52-week high and low as of 2025-05-07 are ₹28.99 and ₹26.55, respectively.
